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Background: The postthrombotic syndrome account for approxi-
mately one half of advanced chronic insufficiency, and its incidence is related
to the severity of the thrombotic event and the quality of the treatment in the
acute phase, but also influenced by the behavior and lifestyle of the patient
(physical activity, weight control and compliance to elastic stockings¼). The
aim of therapeutic education is to help the patient to achieve the required
changes in lifestyle and health related behaviors by improving his knowl-
edge, skills andmotivation, which seem appropriate in patients with high risk
of postthrombotic syndrome. We developed and performed a preliminary
evaluation of a structured therapeutic education program dedicated to the
patients with a recent episode of proximal deep vein thrombosis.
Methods: The education program is organized as a six days course for
small groups of 6 to 10 patients who benefit from, one individual educative
consultation, four group education workshops and six sessions of active
balneotherapy, also aiming at educational objectives. Three training courses
were organized in three different spa resorts specifically dedicated to the care
of patients with venous diseases (La Léchère, Rochefort et Bagnoles de
l’Orne). Main inclusion criteria were a recent (2 years) proximal DVT of
the lower limbs remaining symptomatic but with no skin changes (C0s-C3),
availability for the course and written consent. An evaluation of CIVIQ2
quality of life scale (autoevaluation), and VCSS and Villalta score (by an
independent observer) was performed at inclusion, and at 2 and 6 months
follow-up.
Results: Twelve women and nine (median age 58 years; 20-89) were
enrolled. No dropout was observed during follow-up. Every participant
declared a high level of satisfaction level. Two and six months follow-up
showed a significant improvement of the CIVIQ2 quality of life scale
(P.01), the VCSS (P.05) and the Villalta score (P.01).
Conclusion: This promising results have to be confirmed in a larger
scale randomized controlled study with longer follow-up, which has just
started.
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Background: Iliofemoral Deep Vein Thrombosis (IFDVT) is associ-
ated with a high incidence of the post thrombotic syndrome. The current
CHEST guidelines suggest that catheter directed thrombolysis can be used
for patients with acute IFDVT and severe leg complaints. Current literature
shows that catheter directed thrombolysis increases patency of the affected
tract and may reduced post thrombotic complications, but treatment time
and complications are high. Ultrasounds Accelerated Catheter Directed
Thrombolysis (UACDT) uses ultrasound waves to enhance clot lysis, which
in turn should lower treatment time and bleeding complications with the
same or higher patency rates. We report our clinical experience with
UACDT in patients with acute IFDVT.
Methods: Patients who were treated with UACDT for acute IFDVT
were included in our analysis. Diagnosis of IFDVT was confirmed using
duplex sonography and MR-venography. In additional to the thrombolysis,
stents were placed or AV-fistula created to ensure patency of the treated vein,
if indicated. Main outcome is patency after one year. Secondary outcome
measures are: treatment time, bleeding complications, and pulmonary em-
bolism. Patency was assessed using duplex sonography.
Results: In total 38 patients (average age at intervention 42 years,
range, 5-78 years) were included. They underwent 45 UACDT procedures.
The DVT location was unilateral in 35 patients (23 left side, 12 right) and 3
times bilateral. Average treatment time was 64 hours (range, 20 - 166 hours),
success rate of thrombolysis was 91% (n41), re-thrombosis occurred after
14 (31%) procedures. Additional procedures were required in 50% (n19) of
patients. These additional procedures included PTA and stenting of the venous
tract and 6 open procedures. 4 patients received the UACDT twice and 2
patients received UACDT three times because of recurrent thrombosis or stent
thrombosis. Average follow-up time was 14 months (maximum 31 month,
median 12 months). Major bleeding occurred in two patients (4%) and four
minor bleedings occurred at the insertion point of the catheter (9%). One
pulmonary embolism was encountered. Two patients had fever with positive
blood cultures for S. aureus. Primary patencywas 60% (23/38); primary assisted
patency was equal. Secondary patency was 74% (28/38) after an average of 12
months follow-up. In ten of twelve cases (83%) the first re-thrombosis of the
treated leg occurred within the first two weeks after successful catheter-directed
thrombolysis.
Conclusions: Ultrasound accelerated catheter directed thrombolysis
of acute iliofemoral DVT seems feasible and safe. Supplementary angioplasty
and stenting plays an important role in preventing rethrombosis.
Chronic Venous Insufficiency From An Internist’s Perspective: Results
of the Pri-Med Questionnaire
J. Heller, Johns Hopkins, Baltimore, Md
Background: The purpose of this study was to gain insight into
diagnostic and treatment patterns of venous disease among internal medi-
cine practitioners.
Methods: IRB approval was granted. An eleven question survey was
distributed at the August 2011 Pri-Med Conference in Baltimore, Mary-
land.
Results: 305 questionnaires were returned complete. The geographic
representation likely reflected the location of the conference: 50% Mid
Atlantic, 37% New England, and the remainder in the South, MidWest and
West. The majority of participants (86%) practiced in a community setting.
Of the respondents, 91% were physicians and 9% were advanced level
practitioners. Only 3% of practitioners did not encounter venous disease;
93% prescribed compression stockings. When asked about the next treat-
ment step in a patient with normal pedal pulses and a medial malleolar ulcer,
29%would obtain ankle brachial indices and 24%would begin wound care in
their office. Heterogenous referral patterns were reported. Practitioners
referred to more than a single type of vein specialist. Although 76% referred
to a vascular surgeon, 23% referred to a free standing vein clinic, 9%
radiologist, 3% cardiologist. Further, 34.6% responded that they met resis-
tance to treat when referring venous disease to their vascular surgery
colleagues. 84% would attend a one day course on venous disease.
Conclusions: Although venous disease is commonly seen in the med-
ical practitioner’s office, diagnostic aptitude is varied at best. Referral pat-
terns to vascular surgeons are not routine. The vast majority of physicians are
interested in further education. Further grassroots education is required to
improve diagnosis and treatment in patients with chronic venous disease.
This could lead to earlier intervention thereby decreasing the incidence of
venous stasis ulceration in the United States.
Is There a Relationship Between Increased Body Mass Index and
Primary Venous Disease Severity And Concomitant Primary Deep
Venous Reflux?
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Background: The role of overweight in chronic venous disease is still
controversial. The aim of this study was to evaluate the impact of overweight
and obesity in chronic primary venous disease in relation to disease severity,
using the CEAP and VCSS as well as well as bodyweight on the presence of
concomitant primary deep venous reflux.
Methods: Between October 2005 and September 2010, 1445 consec-
utive patients (2023 limbs) presenting with duplex-ultrasound confirmed
chronic primary venous disease and planned for intervention were evaluated
retrospectively from a prospectively collected database. The patients were
classified according to CEAP classification, the venous clinical severity score
(VCSS) and body mass index (kg/m2), using the WHO definition. Con-
comitant primary deep venous reflux was evaluated and reexamined follow-
ing eradication of the superficial reflux.
Results: There were 636 normal weight patients (890 limbs), BMI
25, 526 overweight patients (740 limbs), BMI 25 to 29.9, and 283 obese
patients (393 limbs), BMI 30 kg/m2. Overweight patients had more
incompetent perforators (P.001), hypertension (P.001) and diabetes
(P.019) than normal weight patients and higher C-class and VCSS
(P.001). Obese patients had more incompetent perforators (P.001),
hypertension (P.001), diabetes (P.004) and primary deep insufficiency
(P.001) than overweight patients as well as higher C-class and VCSS
(P.001). Correlation between the C-class (CEAP classification) and the
severity score (VCSS) was found excellent (r0.80). Obese patients had
more axial reflux than the two other groups. There was no relationship
between disease duration, bodyweight, and severity within each group. After
eradication of superficial reflux, disappearance of preoperative deep reflux
was lowest among obese patients (13.7%) compared to overweight patients,
22.5%.
Conclusions: There was a close relation between bodyweight and
clinical severity of primary venous disease. Both overweight and obesity
appears to be a separate risk factor for increased severity in patients with
chronic primary venous disease without correlation to disease duration.
CEAP and VCSS seem to accurately evaluate disease severity with an
excellent correlation between the two scores. Concomitant primary deep
venous reflux is more often observed in the obese patients, with less
abolishment following eradication of the superficial reflux than observed for
normal weight and overweight patients.
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